Sign In
Last checked at 
2 Jun 2023 07:00
IQE plc
Cardiff, UK
2 June 2023
Director/PDMR Shareholding
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 1 June 2023 that Dr Drew Nelson, Non-Executive Director, has delivered a further 699,647 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to Equities First Holdings ("EFH"), having received a margin call under the terms of his sale and repurchase agreement with EFH, first announced on 06 August 2019 and extended on 29 July 2022 ("the Agreement"). The total number of Ordinary Shares subject to the sale and repurchase under the Agreement is now 12,821,358 Ordinary Shares ("EFH Sale Shares").
Under the terms of the Agreement, Dr Nelson is obligated to repurchase (and EFH is obligated to sell to Dr Nelson) the EFH Sale Shares at the end of a term ended 5 August 2024. The price at which he has sold and is required to repurchase the EFH Sale Shares remains 43.96 pence per share. All other terms under the Agreement, as disclosed on 6 August 2019, remain unchanged.
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1. | Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | |
a) | Name | Dr Andrew Nelson |
2. | Reason for the notification | |
a) | Position / status | PDMR (Non-Executive Director) |
b) | Initial notification / amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | IQE plc |
b) | Legal Entity Identifier | 213800Y33WHD3ESJJP16 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument | Ordinary Shares of 1 pence each in the CompanyGB0009619924 |
b) | Nature of the transaction | Delivered a further 699,647 Ordinary Shares to Equities First Holdings under the terms of a sale and repurchase agreement with Equities First Holdings, first announced on 06 August 2019 |
c) | Price(s) and volume(s) | 699,647 Ordinary Shares |
d) | Aggregated information · Aggregated volume · Aggregated price |
699,647 Ordinary Shares |
e) | Date of the transaction(s) | 1 June 2023 |
f) | Place of the transaction | Outside a trading venue |
Contacts:
IQE plc
+44 (0) 29 2083 9400
Americo Lemos
Tim Pullen
Amy Barlow
Peel Hunt (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Paul Gillam
Richard Chambers
James Smith
Numis (Joint Broker)
+44 (0) 20 7260 1000
Simon Willis
Hugo Rubinstein
Iqra Amin
Headland Consultancy (Financial PR) + 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
ABOUT IQE
http://iqep.com
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:
· Smart Connected Devices
· Communications Infrastructure
· Automotive and Industrial
· Aerospace and Security
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.
Follow the stocks
